Blood lead concentration among oral/inhaled opium users: systematic review and meta-analysis

References

• Ahmadinejad M, Ahmadipour M, Divsalar K. 2019. Blood lead level in opiate addicts hospitalized in the intensive care unit of a trauma referral center in Kerman. Iran Addict Health. 11(1):11–17.
   PubMedGoogle Scholar
• Akhgari M, Moradi F, Ziarati P. 2018. The texture of psychoactive illicit drugs in Iran: adulteration with lead and other active pharmaceutical ingredients. J Psychoactive Drugs. 50(5):451–459.
   PubMed Web of Science ®Google Scholar
• Alinejad S, Aaseth J, Abdollahi M, Hassanian-Moghaddam H, Mehrpour O. 2017. Clinical aspects of opium adulterated with lead in Iran: a review. Basic Clin Pharmacol Toxicol. 122(1):56–64.
   PubMed Web of Science ®Google Scholar
• Amiri M, Amini R. 2012. A comparison of blood-lead level (BLL) in opium-dependent addicts with healthy control group using the graphite furnace/atomic absorption spectroscopy (GF-AAS) followed by chemometric analysis. Iran Red Crescent Med J. 14(8):488–491.
   PubMed Web of Science ®Google Scholar
• Ansari-Moghaddam A, Habybabady RH, Shakiba M, Mirzaei R, Shahriyari F, Aghaei S. 2012. Predictors of initiation, continuation and transition of drug use in south-eastern Iran. J Pak Med Assoc. 62:698–703.
   PubMed Web of Science ®Google Scholar
• Ansari-Moghaddam A, Rakhshani F, Shahraki-Sanavi F, Mohammadi M, Miri-Bonjar M, Bakhshani NM. 2016. Prevalence and patterns of tobacco, alcohol, and drug use among Iranian adolescents: a meta-analysis of 58 studies. Child Youth Serv Rev. 60:68–79.
   Web of Science ®Google Scholar
• Azarion Z, Kazimifar AM, Mehrtash B, Aveisi S. 2016. Examination of clinical and laboratory symptoms of chronic lead poisoning in people consuming oral opium compared to the control group (MD Thesis]. Qazvin University of Medical Sciences, Medical Department, pp. 1–57.
   Google Scholar
• Balduzzi S, Rücker G, Schwarzer G. 2019. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 22(4):153–160.
   PubMed Web of Science ®Google Scholar
• Cleary J, Silbermann M, Scholten W, Radbruch L, Torode J, Cherny NI. 2013. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI). Annal Oncol. 24(11):51–59.
   Google Scholar
• Collett BJ. 2001. Chronic opioid therapy for non-cancer pain. Br J Anaesth. 87(1):133–143.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. 2017. Drugs of abuse. A DEA resource guide: 2017 edition. U.S. Department of Justice, Washington, DC, USA, p. 46.
   Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Esteban M, Castaño A. 2009. Non-invasive matrices in human biomonitoring: a review. Environ Int. 35(2):438–449.
   PubMed Web of Science ®Google Scholar
• Fakoor M, Akhgari M, Shafaroodi H. 2019. Lead poisoning in opium-addicted subjects, its correlation with pyrimidine 5'-nucleotidase activity and liver function tests. Int J Prev Med. 10:36.
   PubMed Web of Science ®Google Scholar
• García-Esquinas E, Pollan M, Tellez-Plaza M, Francesconi KA, Goessler W, Guallar E, Umans JG, Yeh J, Best LG, Navas-Acien A. 2014. Cadmium exposure and cancer mortality in a prospective cohort: the Strong Heart Study. Environ Health Perspect. 122(4):363–370.
   PubMed Web of Science ®Google Scholar
• García-Rico L, Leyva-Perez J, Jara-Marini ME. 2007. Content and daily intake of copper, zinc, lead, cadmium and mercury from dietary supplements in Mexico. Food Chem Toxicol. 45(9):1599–1605.
   PubMed Web of Science ®Google Scholar
• Ghaemi K, Ghoreishi K, Rabiee N, Alinejad S, Farzaneh E, Amirabadi Zadeh A, Abdollahi M, Mehrpour O. 2017. Blood lead levels in asymptomatic opium addicted patients: a case control study. Emergency. 5:e69.
   PubMed Web of Science ®Google Scholar
• Domeneh BH, Tavakoli N, Jafari N. 2014. Blood lead level in opium dependents and its association with anemia: a cross-sectional study from the capital of Iran. J Res Med Sci. 19:939–943.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. 2000. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis.Biometrics.56(2): 455–463.
   PubMed Web of Science ®Google Scholar
• Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A. 2018. Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016–2017. Bull World Health Organ. 96(3):165–172.
   PubMed Web of Science ®Google Scholar
• Hanif S, Ilyas A, Shah MH. 2018. Statical evaluation of trace metals, TSH and T4 in blood serum of thyroid disease patients in comparison with controls. Biol Trace Elem Res. 183(1):58–70.
   PubMed Web of Science ®Google Scholar
• Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S, Amirabadizadeh AR, Zahedi MJ, Moghadam SD, Ahmadi B, Soroush S, Aaseth J, et al. 1985. Lead poisoning among opium users in Iran: an emerging health hazard. Subst Abuse Treat Prev Policy. 12(1):43.
   Google Scholar
• Hedges LV, Olkin I. 2014. Statistical methods for meta-analysis. London: Academic Press.
   Google Scholar
• Higgins J, Thompson SG. 2002. Quantifying heterogeneity in a meta-analysis. Stat Med. 21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Hong YS, Song KH, Chung JY. 2014. Health effects of chronic arsenic exposure. J Prev Med Public Health. 47(5):245–252.
   PubMedGoogle Scholar
• Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. 2010. Opium consumption and risk of bladder cancer: a case-control analysis. Urol Oncol. 28(6):610–616.
   PubMed Web of Science ®Google Scholar
• Karri SK, Saper RB, Kales SN. 2008. Lead encephalopathy due to traditional medicines. Curr Drug Saf. 3(1):54–59.
   PubMedGoogle Scholar
• Ketabchi A, Gharaei M, Ahmadinejad M, Meershekari T. 2005. Evaluation of bladder cancer in opium addicted patients in the Kerman Province, Iran, from 1999 to 2003. J Res Med Sci. 10:355–357.
   Google Scholar
• Khatibi-Moghadam H, Khadem-Rezaiyan M, Afshari R. 2016. Comparison of serum and urine lead levels in opium addicts with healthy control group. Hum Exp Toxicol. 35(8):861–865.
   PubMed Web of Science ®Google Scholar
• Nakhaee S, Mehrpour O. 2018. Opium addiction as new source of lead poisoning: an emerging epidemic in Iran. *Excli J. 17:513–515.
   PubMed Web of Science ®Google Scholar
• Nakhaee S, Amirabadizadeh A, Qorbani M, Lamarine RJ, Mehrpour O. 2020. Opium use and cardiovascular diseases: a systematic review and meta-analysis. Crit Rev Toxicol. 50:201–212.
   PubMed Web of Science ®Google Scholar
• Nemati A, Jafari S, Afshari M, Dahmardeh S, Tabrizian K. 2016. Comparison of blood lead level among oral/inhaled opium addicts and a non-addict control group in southeast of Iran. Addict Health. 8:235–241.
   PubMedGoogle Scholar
• Nouri S, Zoghi A, Sharif MR, Farhang N, Shojaei M. 2018. Evaluation of thyroid hormones in patients with lead poisoning. Tehran Univ Med J. 76(7):477–483.
   Google Scholar
• Oberoi S, Barchowsky A, Wu F. 2014. The global burden of disease for skin, lung, and bladder cancer caused by arsenic in food. Cancer Epidemiol Biomark Prev. 23(7):1187–1194.
   PubMed Web of Science ®Google Scholar
• Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, et al. 2018. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 113(10):1905–1926.
   PubMed Web of Science ®Google Scholar
• Quansah R, Armah FA, Essumang DK, Luginaah I, Clarke E, Marfoh K, Cobbina SJ, Nketiah-Amponsah E, Namujju PB, Obiri S, et al. 2015. Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect. 123(5):412–421.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Alinia P, Aghabiklooei A, Izadi S. 2019. Blood lead level in opium abuse; which is more dangerous? Opium smoking or opium ingestion? Asia Pacific J Med Toxicol. 4:124–129.
   Google Scholar
• Rezaei Tavirani M, Heidari Beigvand HH. 2019. Evaluation of clinical symptoms and serum lead level in patients with history of oral opium use being admitted to Hazrat Rasoul Akram, Firoozgar, Firoozabadi and Haft Tir Hospitals, Tehran. *JPRI. 31(6):1–8.
   Google Scholar
• Ritchie H, Roser M. 2020. Drug use. Published online at: ourworldindata.org (last access: 13 May 2020).
   Google Scholar
• Rosen L, Katzman K. 2014. Afghanistan: Drug Trafficking and the 2014 Transition Washington: The Congressional Research Service, 2014. Available on: https://fas.org/sgp/crs/row/R43540.pdf. (Last access: 19 May 2020).
   Google Scholar
• Salehi H, Sayadi AR, Tashakori M, Yazdandoost R, Soltanpoor N, Sadeghi H, AghaeeAfshar M. 2009. Comparison of serum lead level in oral opium addicts with healthy control group. Arch Iran Med. 12:555–558.
   PubMed Web of Science ®Google Scholar
• Schimmel J, Nakhaee S, Mehrpour O. 2018. Metal and bacterial contamination of illicit drugs. Daru. 26(2):91–92.
   PubMed Web of Science ®Google Scholar
• Schwarzer G, Carpenter JR, Rücker G. 2015. Meta-analysis with R. London: Springer International Publishing.
   Google Scholar
• Shafikhani AA, Kazemifar AM. 2019. Comparison of blood lead levels between oral and inhalation opium addicts and its relationship with hematological parameters. Indian J Forensic Med Toxicol. 13(1):326–331.
   Google Scholar
• Singh VP, Singh N, Jaggi AS. 2013. A review on renal toxicity profile of common abusive drugs. Korean J Physiol Pharmacol. 17(4):347–357.
   PubMed Web of Science ®Google Scholar
• Sistrom CL, Mergo PJ. 2000. A simple method for obtaining original data from published graphs and plots. Am J Roentgenol. 174(5):1241–1244.
   PubMed Web of Science ®Google Scholar
• Soeken KL, Sripusanapan A. 2003. Assessing publication bias in meta-analysis. Nurs Res. 52(1):57–60.
   PubMed Web of Science ®Google Scholar
• Soltaninejad K, Shadnia S. 2018. Lead poisoning in opium abuser in Iran: a systematic review. Int J Prev Med. 9:3–18.
   PubMed Web of Science ®Google Scholar
• UNODC. 2015. World Drug Report 2015. Vienna, Austria: United Nations Office on drugs and Crime.
   Google Scholar
• Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, McCorry D, Bagary M, Mignini L, Khan KS, Zamora J, Thangaratinam S, *EMB-CONNECT Collaboration. 2015. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 386(10006):1845–1852.
   PubMed Web of Science ®Google Scholar
• Viechtbauer W. 2010. Conducting meta-analyses in R with the metafor package. *J Stat Softw. 36(3):1–48.
   Web of Science ®Google Scholar
• Wani AL, Ara A, Usmani JA. 2015. Lead toxicity: a review. Interdiscip Toxicol. 8(2):55–64.
   PubMedGoogle Scholar
• Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. 2009. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available on: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. (Last access: 8 August 2018).
   Google Scholar
• Zamani N, Hassanian-Moghaddam H, Bahrami-Motlagh H, Ahmadi S, Phillips S. 2019. Lead poisoning due to ingestion of lead-contaminated opium: a diagnostic study on patients' imaging findings. J Trace Elem Med Biol. 55: 26–32.
   PubMed Web of Science ®Google Scholar
• Zamani N, Mehrpour O, Hassanian-Moghaddam H, Jalali M, Amirabadizadeh A, Samie S, Sabeti S, Kolahi A-A. 2020. A preliminary report on the largest ongoing outbreak of lead toxicity in Iran. Sci Rep. 10(1):11797.
   PubMed Web of Science ®Google Scholar